It may be time to rethink that evening tipple – new research has found that drinking alcohol is linked to Alzheimer’s disease

Some of the genes affected by alcohol and inflammation are also implicated in processes that clear amyloid beta – the protein that forms globs of plaques in the brain and which contributes to neuronal damage and the cognitive impairment associated with Alzheimer’s disease.

This is according to research by the University of Illinois at Chicago.

But wait, we thought that alcohol could protect against Alzheimer’s disease?

That’s right, previous studies have indicated that alcohol has a protective effect while other studies linked alcohol to the development of this neurocognitive disease.

WIN a R 2,000 Woolworths Voucher

Subscribe to our Free Daily All4Women Newsletter to enter

Another recent study suggested that alcohol consumption, and its impact on the immune system and inflammation in the brain, may be the vehicle through which alcohol might exert its influence on the development of Alzheimer’s disease.

However, no previous studies have directly evaluated which genes are affected by alcohol in cells in the brain involved in protecting against Alzheimer’s disease.

Related: A habit that makes women 90% less likely to develop dementia

The science

For those of you who want to know how the latest study was done, researchers exposed rat microglial cells to alcohol, pro-inflammatory chemicals called cytokines, or alcohol and cytokines in the lab for 24 hours.

They then looked at changes in gene expression under each condition. They also looked at the impact of alcohol exposure on the cells’ ability to engulf amyloid beta.

Dr Douglas Feinstein, professor of anesthesiology in the University of Illinois at Chicago College of Medicine, along with other researchers wanted to determine which genes were affected by both alcohol and high levels of inflammation in microglial cells. These are cells that support neural cells in the brain and elsewhere in the body. One of their functions is to engulf and digest the amyloid beta protein plaques characteristic of Alzheimer’s disease in a process known as phagocytosis. Microglial cells are also known to express high levels of inflammatory markers due to chronic alcohol exposure.

They found that gene expression was altered for 312 genes under the alcohol condition; for 3 082 for the pro-inflammatory condition, and 3 552 for the alcohol and pro-inflammatory condition. Changes in gene expression – either an increase or decrease in expression compared to normal levels – averaged about 16 percent and ranged from a 50 percent decrease to a 72 percent increase. Just a handful of genes were involved in both phagocytosis and inflammation.

The results suggest that alcohol impedes the ability of mircroglia to keep the brain clear of amyloid beta and may contribute to the development of Alzheimer’s disease.

“Among the genes we saw altered were many involved in phagocytosis, which is the first time this has been shown,” Feinstein said. “While these studies were performed in isolated cells, our results suggest that alcohol impedes the ability of mircroglia to keep the brain clear of amyloid beta and may contribute to the development of Alzheimer’s disease.”

After the researchers exposed the cells to alcohol levels at doses that are comparable to those found in humans after binge drinking or in heavy drinkers, they found that microglial phagocytosis was significantly suppressed by about 15 percent after one hour.

“We didn’t continue the study to see whether phagocytosis was further impaired after longer exposures to alcohol,” Feinstein said, “but it appears that these changes in microglial cells could be a contributing factor to the development of Alzheimer’s disease.”

Source: University of Illinois at Chicago via www.sciencedaily.com

While All4Women endeavours to ensure health articles are based on scientific research, health articles should not be considered as a replacement for professional medical advice. Should you have concerns related to this content, it is advised that you discuss them with your personal healthcare provider.